Iovance Biotherapeutics Inc (IOVA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2016 | 03-2016 | 12-2015 | 09-2015 | 06-2015 | |
| Operating Expenses | 11,727 | 7,010 | 8,479 | 7,643 | 6,440 |
| Operating Income | -11,727 | -7,010 | -8,479 | -7,643 | -6,440 |
| Other Income | 164 | 126 | 119 | 8 | 73 |
| Pre-tax Income | -11,563 | -6,884 | -8,360 | -7,635 | -6,367 |
| Net Income Continuous | -11,563 | -6,884 | -8,360 | -7,635 | -6,367 |
| Net Income | $-11,563 | $-6,884 | $-8,360 | $-7,635 | $-6,367 |
| EPS Basic Total Ops | -0.23 | -0.14 | -0.18 | -0.16 | -0.14 |
| EPS Basic Continuous Ops | -0.23 | -0.14 | -0.18 | -0.16 | -0.14 |
| EPS Diluted Total Ops | -0.23 | -0.14 | -0.18 | -0.16 | -0.14 |
| EPS Diluted Continuous Ops | -0.23 | -0.14 | -0.18 | -0.16 | -0.14 |
| EBITDA(a) | $-11,456 | $-6,741 | $-8,171 | $-7,377 | $-6,200 |